Rebeca E Melgar-Bieberach
Internal medicinePublic healthVirologyRenal functionPediatricsVirusLow molecular weight heparinHeparinLivedoAnticoagulantAnorexiaDisseminated intravascular coagulationDiseaseNauseaVomitingMyocarditisAbdominal painCoagulation DisorderSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineGastroenterology
Publications 3
The disease caused by a new coronavirus, which started in 2019, was named COVID-19 and declared a pandemic on March 11, 2020 by the World Health Organization. Although it is true that the first reports emphasized the respiratory manifestations of this disease as an initial clinical presentation, little by little cases with different initial manifestations began to appear, involving other systems. In cases where central nervous system involvement was identified, the most frequent findings were di...
1 CitationsSource
Infection with the SARS-CoV-2 virus and the development of all manifestations of COVID-19, predisposes to arterial and venous thromboembolic disease. The coagulation system can be activated by various viruses, including SARS-CoV-2. Vascular endothelial damage, added to the development of disseminated intravascular coagulation, affects the prognosis and mortality from this disease. Treatment is aimed at the prevention, early detection and timely interventions of all coagulation disorders generate...
1 CitationsSource